SitemapPages
- Chemokine receptor assays
- Company
- Contact Us
- hERG binding assay
- hERG binding assay (GDhERG)
- Histamine H1 assay (GDH11)
- Histamine H1 assay (GDH12)
- Histamine H1 assay (GDH13)
- Histamine H1 assay (GDH14)
- Histamine H1 assay (GDH15)
- Histamine H1 assay (GDH16)
- Histamine H1 assay (GDH17)
- Histamine H1 assay (GDH18)
- Histamine H2 assay (GDH21)
- Histamine H2 assay (GDH23)
- Histamine H2 assay (GDH25)
- Histamine H3 assay (GDH31)
- Histamine H3 assay (GDH32)
- Histamine H3 assay (GDH33)
- Histamine H3 assay (GDH34)
- Histamine H3 assay (GDH35)
- Histamine H3 assay (GDH36)
- Histamine H4 assay (GDH41)
- Histamine H4 assay (GDH410)
- Histamine H4 assay (GDH411)
- Histamine H4 assay (GDH412)
- Histamine H4 assay (GDH42)
- Histamine H4 assay (GDH43)
- Histamine H4 assay (GDH44)
- Histamine H4 assay (GDH45)
- Histamine H4 assay (GDH46)
- Histamine H4 assay (GDH47)
- Histamine H4 assay (GDH48)
- Histamine H4 assay (GDH49)
- Histamine receptor assays
- Investors
- News Archieve
- Pipeline
- Research & Development
- Services
- Sitemap
- Vacancies
- Welcome to Griffin Discoveries!
News posts
- H4R Development candidate identified with long receptor residence time – 10 February 2012
- Patent Application for new series of histamine H4 antagonists filed. – 21 November 2011
- Griffin Discoveries launches comprehensive histamine receptor profiling service – 31 July 2011
- Griffin Discoveries to participate at CHI Drug Discovery Chemistry 2011 – 12 March 2011
- New dual action non-imidazole H1/H4 antagonists identified. – 12 February 2011
